Free Shipping on all orders
Free Shipping on all orders
$119
Save $10 on every bottle – Use code SAVE10 at checkout.
1000 in stock
Free Returns
Free Shipping
USA Made
Thymosin Alpha-1 (Tα1) – High Purity Research Peptide
Thymosin Alpha-1 is a synthetic version of a naturally occurring peptide fragment derived from prothymosin alpha, a protein found in the thymus gland. This peptide is widely studied in scientific and clinical research for its potential role in modulating immune system activity.
Known for its stability and high bioactivity in laboratory conditions, Thymosin Alpha-1 is used in research exploring immune response pathways, cell signaling, and potential therapeutic applications. Researchers often focus on its interactions with T-cells and its effects on cytokine production.
Key Features:
≥99% purity (HPLC tested)
For laboratory research use only
Stored under controlled conditions to maintain stability
Usage Notice: This product is intended for in vitro research and laboratory use only. It is not for human consumption, medical use, or veterinary purposes.
Orders placed before 1 PM EST ship same day. We use USPS for most of our deliveries. You can expect your parcel within 2-5 business days from when it leaves our warehouse.
BPC-157 + TB-500, commonly referred to as the Wolverine stack, is a synthetic peptide blend formulated for advanced research into cellular repair, tissue regeneration, and inflammatory modulation.
The blend combines two well-studied peptides—BPC-157, derived from a protein found in gastric juice, and TB-500, a synthetic fragment of the naturally occurring Thymosin Beta-4 (TB-4) peptide.
TB-500 is a synthetic peptide fragment designed to mimic the active region of Thymosin Beta-4, but with greater stability and shelf life, making it more practical for research storage and use. TB-500 promotes cell migration, blood vessel formation, and muscle fiber regeneration—key mechanisms in studies focused on soft tissue injury and cardiac repair.
Thymosin Beta-4 (TB-4) is a naturally occurring peptide in the human body, composed of 43 amino acids. It plays roles in cell migration, inflammation regulation, wound healing, and angiogenesis. However, full-length TB-4 is biologically fragile, expensive to synthesize, and has poor shelf stability, making it less practical for research or commercial use.
TB-500, by contrast, is a synthetic peptide fragment that mimics the key active region of Thymosin Beta-4—specifically the portion responsible for its regenerative and wound-healing effects.
| Summary: While TB-500 and TB-4 share similar biological targets, they are not identical. TB-500 is preferred in research for its longer half-life, resistance to degradation, and compatibility with BPC-157’s dosing protocols. |
TB-500 and BPC-157 are frequently combined in research due to their complementary dosing protocols. Both peptides are typically administered in similar cycle lengths and dosing frequencies, which simplifies their co-administration in experimental settings.
This makes a pre-formulated blend like Wolverine especially practical, allowing researchers to explore synergistic effects in tissue repair, inflammation modulation, and recovery without the complexity of managing separate compounds or mismatched schedules.
This compatibility is one reason the two peptides are often combined in preclinical models: they target overlapping but distinct pathways, with BPC-157 more focused on tendon, ligament, and gastrointestinal healing, and TB-500 on muscle regeneration and vascular growth.
When used together in research, the Wolverine blend provides a means of studying potential synergistic interactions on systemic recovery, inflammation control, and accelerated healing across multiple tissue types.
For research use only. Not for human or veterinary use. This compound is not intended for therapeutic or diagnostic purposes and has not been evaluated by regulatory agencies for safety or efficacy in humans.
The combination of BPC-157 and TB-500 has drawn interest in preclinical studies due to their complementary mechanisms in supporting tissue repair, cellular regeneration, and inflammation control.
Although these peptides are still under investigation and not approved for human use, research models suggest several potential biological roles.
BPC-157, a stable gastric pentadecapeptide, has been shown in animal studies to accelerate healing in muscle, tendon, and nerve tissue by enhancing angiogenesis and modulating growth factor expression. It may also influence fibroblast activity and extracellular matrix remodeling, contributing to structural tissue repair.
TB-500, a synthetic version of the naturally occurring Thymosin Beta-4 peptide fragment, appears to promote cell migration, differentiation, and wound healing by regulating actin polymerization and increasing vascular endothelial growth factor (VEGF) activity.
This is particularly relevant in muscle and cardiovascular research models.
Both peptides have been observed to reduce pro-inflammatory cytokine levels and oxidative stress in various tissue injury models. BPC-157, in particular, has demonstrated protective effects against NSAID-induced gastric damage and may act on nitric oxide pathways to maintain vascular homeostasis.
⚠️ Disclaimer: These findings are derived from non-human studies. No therapeutic claims are made. This product is for laboratory research purposes only.
While BPC-157 and TB-500 are still under investigation and not approved for therapeutic use, preclinical studies have explored their potential in a range of biological contexts. The Wolverine blend offers researchers a practical formulation to study multi-pathway regenerative processes.
Animal models have shown that BPC-157 may support the healing of muscles, tendons, ligaments, and nerves, potentially by enhancing angiogenesis, reducing inflammation, and stimulating fibroblast activity.
A study by Chang et al. (2011) investigated the effects of BPC-157 on tendon healing in rats. The researchers found that BPC-157 significantly accelerated the outgrowth of tendon fibroblasts from tendon explants. Additionally, BPC-157 enhanced cell survival under oxidative stress and increased the migration of tendon fibroblasts in a dose-dependent manner.
TB-500 complements these findings with data suggesting effects on myogenesis, muscle fiber regeneration, and wound repair, particularly through its role in actin regulation and vascular endothelial growth factor (VEGF) expression.
Both peptides have demonstrated anti-inflammatory activity in rodent models. BPC-157 has been observed to downregulate pro-inflammatory cytokines and protect against NSAID-induced tissue damage, while TB-500 may modulate macrophage activity and support immune cell migration.
A study by Ilic et al. (2011) examined the effects of BPC-157 on rats subjected to diclofenac-induced toxicity, which typically causes significant gastrointestinal, liver, and brain lesions. The administration of BPC-157 resulted in a marked reduction of these lesions, suggesting its protective role against NSAID-induced organ damage.
Similarly, TB-500 is a synthetic peptide fragment of Thymosin Beta-4 (TB-4), which has been associated with actin regulation and cell migration, which are crucial processes in immune response and tissue repair. TB-500 is designed to mimic these properties, and researchers often utilize it in studies focusing on wound healing and inflammation.
Due to overlapping properties, BPC-157 and TB-500 are frequently studied together in the context of systemic injury recovery. Research has explored their combined use in facilitating recovery following soft tissue trauma, surgery, or overuse injury, although further data is needed.
Wolverine is a research-only peptide blend combining BPC-157 and TB-500, formulated for convenience and compatibility in studies focused on tissue regeneration, inflammation modulation, and post-injury recovery.
This product is intended for laboratory research purposes only and is not approved for human or veterinary use.
| Feature | BPC-157 + TB-500 (Wolverine) | BPC-157 Alone | TB-500 Alone | Thymosin Alpha-1 (Tα1) |
| Type | Peptide blend (regenerative peptides) | Single peptide (gut protection, tissue repair) | Single peptide (actin regulation, tissue regeneration) | Single peptide (immune modulation) |
| Primary Research Targets | Tissue repair, inflammation modulation, angiogenesis | Tissue healing, anti-inflammatory, gut protection | Wound healing, cell migration, angiogenesis | Immune response, inflammation control |
| Mechanism Complexity | Combined multi-pathway effects | Focused on fibroblast and endothelial cell activity | Focused on actin cytoskeleton and cell migration | Immune system modulation and cytokine regulation |
| Research Stage | Preclinical/early clinical research | Preclinical and some clinical studies | Preclinical research | Preclinical and clinical research |
| Observed Benefits (Preclinical Research) | Enhanced soft tissue healing and recovery, anti-inflammatory effects | Accelerated healing of muscles, tendons, ligaments | Improved wound healing, cell motility | Immune enhancement, inflammation reduction |
| Dosing Frequency | Typically cyclic, 2–4 weeks | Cyclic, usually daily or twice daily | Cyclic, similar to BPC-157 dosing | Varies, often subcutaneous injection multiple times per week |
| Approval Status | Research use only | Research use only | Research use only | Research use only / Clinical trials |
| Disclaimer | For research only, not for human use | For research only, not for human use | For research only, not for human use | For research only, not approved for human use |
Most research on BPC-157, TB-500, and their combination has been conducted in preclinical animal models.
To date, studies have reported minimal adverse effects at typical research-level dosages. However, it is important to note that there is insufficient data on safety or side effects in humans, and these peptides remain strictly for laboratory research purposes only.
Researchers should exercise caution and adhere to all regulatory guidelines when handling and studying these compounds.
Evolve Peptides ensures third-party laboratory testing is performed on all peptide products, including Wolverine, to verify purity, potency, and quality. Certificates of Analysis (COAs) are available for transparency and can be provided upon request or downloaded where applicable. We are committed to supporting reliable and reproducible research outcomes.
This product is intended for laboratory research purposes only and is not approved for human or veterinary use. It is not for resale, diagnostic, or therapeutic applications.
doi: 10.1152/japplphysiol.00945.2010. Epub 2010 Oct 28. https://pubmed.ncbi.nlm.nih.gov/10385604/
Orders placed before 1 PM EST ship same day. We use USPS for most of our deliveries. You can expect your parcel within 2-5 business days from when it leaves our warehouse.
BPC-157 + TB-500, commonly referred to as the Wolverine stack, is a synthetic peptide blend formulated for advanced research into cellular repair, tissue regeneration, and inflammatory modulation.
The blend combines two well-studied peptides—BPC-157, derived from a protein found in gastric juice, and TB-500, a synthetic fragment of the naturally occurring Thymosin Beta-4 (TB-4) peptide.
TB-500 is a synthetic peptide fragment designed to mimic the active region of Thymosin Beta-4, but with greater stability and shelf life, making it more practical for research storage and use. TB-500 promotes cell migration, blood vessel formation, and muscle fiber regeneration—key mechanisms in studies focused on soft tissue injury and cardiac repair.
Thymosin Beta-4 (TB-4) is a naturally occurring peptide in the human body, composed of 43 amino acids. It plays roles in cell migration, inflammation regulation, wound healing, and angiogenesis. However, full-length TB-4 is biologically fragile, expensive to synthesize, and has poor shelf stability, making it less practical for research or commercial use.
TB-500, by contrast, is a synthetic peptide fragment that mimics the key active region of Thymosin Beta-4—specifically the portion responsible for its regenerative and wound-healing effects.
| Summary: While TB-500 and TB-4 share similar biological targets, they are not identical. TB-500 is preferred in research for its longer half-life, resistance to degradation, and compatibility with BPC-157’s dosing protocols. |
TB-500 and BPC-157 are frequently combined in research due to their complementary dosing protocols. Both peptides are typically administered in similar cycle lengths and dosing frequencies, which simplifies their co-administration in experimental settings.
This makes a pre-formulated blend like Wolverine especially practical, allowing researchers to explore synergistic effects in tissue repair, inflammation modulation, and recovery without the complexity of managing separate compounds or mismatched schedules.
This compatibility is one reason the two peptides are often combined in preclinical models: they target overlapping but distinct pathways, with BPC-157 more focused on tendon, ligament, and gastrointestinal healing, and TB-500 on muscle regeneration and vascular growth.
When used together in research, the Wolverine blend provides a means of studying potential synergistic interactions on systemic recovery, inflammation control, and accelerated healing across multiple tissue types.
For research use only. Not for human or veterinary use. This compound is not intended for therapeutic or diagnostic purposes and has not been evaluated by regulatory agencies for safety or efficacy in humans.
The combination of BPC-157 and TB-500 has drawn interest in preclinical studies due to their complementary mechanisms in supporting tissue repair, cellular regeneration, and inflammation control.
Although these peptides are still under investigation and not approved for human use, research models suggest several potential biological roles.
BPC-157, a stable gastric pentadecapeptide, has been shown in animal studies to accelerate healing in muscle, tendon, and nerve tissue by enhancing angiogenesis and modulating growth factor expression. It may also influence fibroblast activity and extracellular matrix remodeling, contributing to structural tissue repair.
TB-500, a synthetic version of the naturally occurring Thymosin Beta-4 peptide fragment, appears to promote cell migration, differentiation, and wound healing by regulating actin polymerization and increasing vascular endothelial growth factor (VEGF) activity.
This is particularly relevant in muscle and cardiovascular research models.
Both peptides have been observed to reduce pro-inflammatory cytokine levels and oxidative stress in various tissue injury models. BPC-157, in particular, has demonstrated protective effects against NSAID-induced gastric damage and may act on nitric oxide pathways to maintain vascular homeostasis.
⚠️ Disclaimer: These findings are derived from non-human studies. No therapeutic claims are made. This product is for laboratory research purposes only.
While BPC-157 and TB-500 are still under investigation and not approved for therapeutic use, preclinical studies have explored their potential in a range of biological contexts. The Wolverine blend offers researchers a practical formulation to study multi-pathway regenerative processes.
Animal models have shown that BPC-157 may support the healing of muscles, tendons, ligaments, and nerves, potentially by enhancing angiogenesis, reducing inflammation, and stimulating fibroblast activity.
A study by Chang et al. (2011) investigated the effects of BPC-157 on tendon healing in rats. The researchers found that BPC-157 significantly accelerated the outgrowth of tendon fibroblasts from tendon explants. Additionally, BPC-157 enhanced cell survival under oxidative stress and increased the migration of tendon fibroblasts in a dose-dependent manner.
TB-500 complements these findings with data suggesting effects on myogenesis, muscle fiber regeneration, and wound repair, particularly through its role in actin regulation and vascular endothelial growth factor (VEGF) expression.
Both peptides have demonstrated anti-inflammatory activity in rodent models. BPC-157 has been observed to downregulate pro-inflammatory cytokines and protect against NSAID-induced tissue damage, while TB-500 may modulate macrophage activity and support immune cell migration.
A study by Ilic et al. (2011) examined the effects of BPC-157 on rats subjected to diclofenac-induced toxicity, which typically causes significant gastrointestinal, liver, and brain lesions. The administration of BPC-157 resulted in a marked reduction of these lesions, suggesting its protective role against NSAID-induced organ damage.
Similarly, TB-500 is a synthetic peptide fragment of Thymosin Beta-4 (TB-4), which has been associated with actin regulation and cell migration, which are crucial processes in immune response and tissue repair. TB-500 is designed to mimic these properties, and researchers often utilize it in studies focusing on wound healing and inflammation.
Due to overlapping properties, BPC-157 and TB-500 are frequently studied together in the context of systemic injury recovery. Research has explored their combined use in facilitating recovery following soft tissue trauma, surgery, or overuse injury, although further data is needed.
Wolverine is a research-only peptide blend combining BPC-157 and TB-500, formulated for convenience and compatibility in studies focused on tissue regeneration, inflammation modulation, and post-injury recovery.
This product is intended for laboratory research purposes only and is not approved for human or veterinary use.
| Feature | BPC-157 + TB-500 (Wolverine) | BPC-157 Alone | TB-500 Alone | Thymosin Alpha-1 (Tα1) |
| Type | Peptide blend (regenerative peptides) | Single peptide (gut protection, tissue repair) | Single peptide (actin regulation, tissue regeneration) | Single peptide (immune modulation) |
| Primary Research Targets | Tissue repair, inflammation modulation, angiogenesis | Tissue healing, anti-inflammatory, gut protection | Wound healing, cell migration, angiogenesis | Immune response, inflammation control |
| Mechanism Complexity | Combined multi-pathway effects | Focused on fibroblast and endothelial cell activity | Focused on actin cytoskeleton and cell migration | Immune system modulation and cytokine regulation |
| Research Stage | Preclinical/early clinical research | Preclinical and some clinical studies | Preclinical research | Preclinical and clinical research |
| Observed Benefits (Preclinical Research) | Enhanced soft tissue healing and recovery, anti-inflammatory effects | Accelerated healing of muscles, tendons, ligaments | Improved wound healing, cell motility | Immune enhancement, inflammation reduction |
| Dosing Frequency | Typically cyclic, 2–4 weeks | Cyclic, usually daily or twice daily | Cyclic, similar to BPC-157 dosing | Varies, often subcutaneous injection multiple times per week |
| Approval Status | Research use only | Research use only | Research use only | Research use only / Clinical trials |
| Disclaimer | For research only, not for human use | For research only, not for human use | For research only, not for human use | For research only, not approved for human use |
Most research on BPC-157, TB-500, and their combination has been conducted in preclinical animal models.
To date, studies have reported minimal adverse effects at typical research-level dosages. However, it is important to note that there is insufficient data on safety or side effects in humans, and these peptides remain strictly for laboratory research purposes only.
Researchers should exercise caution and adhere to all regulatory guidelines when handling and studying these compounds.
Evolve Peptides ensures third-party laboratory testing is performed on all peptide products, including Wolverine, to verify purity, potency, and quality. Certificates of Analysis (COAs) are available for transparency and can be provided upon request or downloaded where applicable. We are committed to supporting reliable and reproducible research outcomes.
This product is intended for laboratory research purposes only and is not approved for human or veterinary use. It is not for resale, diagnostic, or therapeutic applications.
doi: 10.1152/japplphysiol.00945.2010. Epub 2010 Oct 28. https://pubmed.ncbi.nlm.nih.gov/10385604/
Orders placed before 1 PM EST ship same day. We use USPS for most of our deliveries. You can expect your parcel within 2-5 business days from when it leaves our warehouse.
Orders placed before 1 PM EST ship same day.
We use USPS for most of our deliveries. You can expect your parcel within 2-5 business days from when it leaves our warehouse.
Earn more points for different actions, and turn those points into awesome rewards.
Earn 1 point for every $1 spent
Earn 100 points
Apex Peptides is a US-based company specializing in 99%+ purity peptides for research use. We pride ourselves on our unwavering commitment to transparency and trust. Each peptide vial you purchase from us is linked to its batch’s Certificates of Analysis (COA) from independent third-party laboratories. These reports detail the results of the peptide you are holding in your hand, ensuring you have complete confidence in the purity and quality of the research peptides you receive. Our mission is your success in research.
Peptides are short chains of amino acids linked by peptide bonds, shorter than proteins, typically ranging from 2 to 50 amino acids. They serve various biological functions, including acting as hormones, enzymes, and signaling molecules, and can have antimicrobial properties. Peptides are synthesized naturally in living organisms and can also be created in the lab for research and medical applications. At Apex Peptides, we offer a range of high-quality research peptides designed for scientific and medical research. Our peptides are used in studies related to biochemistry, molecular biology, and pharmacology.
Our peptides are stored at below-freezing temperatures to preserve their potency, and supplied in lyophilized (freeze-dried) powder form, a state-of-the-art preparation method essential for preserving their integrity and effectiveness. For reconstitution, we recommend using Bacteriostatic Water (BAC Water), available for purchase with our peptides. Our frozen storage facilities and careful packaging ensures that our peptides maintain their exceptional quality from our facility to your laboratory.
Yes, and we will gladly replace any peptides used during the testing process!
We fully support independent product testing. If you opt to validate our products through a third-party laboratory, we are happy to replace any items used during the testing process. To initiate this, please share the test results along with your order number, and we will promptly replace the tested products at no cost. Our confidence in the quality of our products is reflected in our commitment to facilitating independent blind tests conducted by our valued customers.
At this time, we are only serving the United States. However, we are planning to expand into Europe shortly, so subscribe to our newsletter below and we’ll let you know as soon as we start accepting international orders!
We recognize the importance of prompt delivery in research settings. This is why we have optimized our order processing system. Orders are usually processed and dispatched within 1-2 business days after confirmation. Standard shipping typically takes 3-5 business days, while expedited shipping usually arrives in 1-2 business days. Although these timeframes are standard, they are not guaranteed. You will receive a confirmation email with detailed delivery and tracking information, allowing you to monitor your order’s progress.
If you have any additional questions, our team is ready to help you anytime. Click the button below or use our live chat.
1000 in stock
© 2025, Apex Peptides
ALL content provided by APEX is for general informational purposes only. The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
This site is not part of the Facebook website or Facebook Inc. Additionally, this site is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of FACEBOOK, Inc.
